Hartford Healthcare Hls FundHIAHX
Type
Mutual fund
Peer group
US equity: Healthcare
Net assets
$104.5M
Expense ratio
0.94%
1-year return
+9.6%
3 years, a year
+6.2%
5 years, a year
+2.5%
Holdings
86
What it aims to do.
The Fund seeks long-term capital appreciation.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| LLY Eli Lilly & Co | 12.09% |
| MRK Merck & Co Inc | 6.71% |
| JNJ Johnson & Johnson | 6.05% |
| UNH UnitedHealth Group Inc | 4.11% |
| ISRG Intuitive Surgical Inc | 3.53% |
| ABBV AbbVie Inc | 3.19% |
| ABT Abbott Laboratories | 2.88% |
| DHR Danaher Corp | 2.84% |
| EW Edwards Lifesciences Corp | 2.73% |
| VRTX Vertex Pharmaceuticals Inc | 2.50% |
More on HIAHX.
- HIAHX overview
- HIAHX holdings
- HIAHX risk
- HIAHX costs
- HIAHX money in and out
- HIAHX share classes
- Compare HIAHX with other funds
Returns after fees, from the fund's SEC filings up to Mar 2026. Past returns are not a promise. Not financial advice.